Latin America Infusion Pump Market - Forecast To 2030
商品番号 : SMB-87073
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年9月 |
| ページ数 | 297 |
| 図表数 | 319 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、ラテンアメリカの輸液ポンプ市場を分析し、機器・消耗品、がんの種類、処置、エンドユーザー、地域といった様々なセグメントに基づいて市場規模と将来の成長可能性を予測しています。また、主要企業の競合分析に加え、企業概要、サービス内容、最近の動向、主要な市場戦略も掲載しています。
本レポートは、ラテンアメリカにおける輸液ポンプ市場全体および各サブセグメントの収益数値に関する近似値に関する情報を提供し、市場リーダー企業および新規参入企業にとって役立ちます。また、本レポートは、ステークホルダーが競争環境を理解し、事業のポジショニングを改善し、適切な市場開拓戦略を策定するための洞察を深めるのに役立ちます。さらに、本レポートは、ステークホルダーが市場の動向を把握し、主要な市場牽引要因、制約要因、課題、そして機会に関する情報を提供するのにも役立ちます。
ラテンアメリカの輸液ポンプ市場は、予測期間中に6.2%のCAGRで成長し、2025年の7億4,000万米ドルから2030年には10億米ドルに達すると予測されています。
ラテンアメリカの輸液ポンプ市場は、慢性疾患の増加、人口動態の変化、医療施設の改善といった要因に支えられ、着実に成長しています。糖尿病、がん、心血管疾患といった疾患は、この地域で増加傾向にあり、薬剤の正確かつ継続的な投与が求められるケースが多くなっています。輸液ポンプは、特に長期治療を必要とする患者に対し、医師が正確な治療を提供する上で重要な役割を果たします。高齢者人口の増加も、この需要に拍車をかけています。高齢者は通常、頻繁かつ正確な薬剤投与を必要とするためです。加えて、腫瘍学および集中治療の需要増加も、ラテンアメリカの病院や診療所にとって輸液ポンプを不可欠なものにしています。
The Latin America infusion pumps market is projected to reach USD 1.00 billion by 2030 from USD 0.74 billion in 2025, at a CAGR of 6.2% during the forecast period.
The infusion pumps market in Latin America is growing steadily, supported by factors such as rising chronic diseases, changing demographics, and better healthcare facilities. Conditions like diabetes, cancer, and cardiovascular disorders are becoming more common in the region and often require precise and continuous delivery of medicines. Infusion pumps help doctors provide accurate treatment, especially for patients who need long-term care. The growing elderly population also adds to this demand, as older people usually need frequent and controlled drug administration. Along with this, the increasing need for oncology and critical care therapies makes infusion pumps essential for hospitals and clinics across Latin America.
By product, the accessories & consumables segment accounted for the largest share of the market in 2024.
By product, the Latin America infusion pumps market has been segmented into accessories & consumables and devices. The accessories & consumables segment accounted for the largest share of the infusion pumps market in 2024. The accessories & consumables segment is driven by the growing installed base of infusion pumps and the recurring need for disposables like IV sets, catheters, and tubing. The rise in long-term therapies and hospital admissions also increases demand for regular replacement and maintenance components.
By product (devices), the volumetric infusion pumps segment accounted for the largest market share in 2024.
Based on devices, the Latin America infusion pumps market is segmented into volumetric infusion pumps, insulin pumps, enteral infusion pumps, ambulatory infusion pumps, syringe infusion pumps, patient-controlled analgesia (PCA) pumps, and implantable infusion pumps. The volumetric infusion pumps segment accounted for the largest infusion pump devices market share in 2024. The growth of the volumetric infusion pumps segment in the LATAM market is driven by the rising prevalence of chronic diseases necessitating precise fluid administration and the expansion of healthcare infrastructure across the region. Additionally, adopting advanced infusion technologies, including smart pumps with enhanced safety features, and increased healthcare spending contribute to the segment’s expansion.
By application, the diabetes segment accounted for the largest share of the market in 2024.
Based on application, the Latin America infusion pumps market is segmented into chemotherapy/oncology, diabetes management, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and other applications (includes infectious diseases, autoimmune diseases, and diseases of the heart, kidney, lung, and liver). The diabetes segment accounted for the largest market share owing to the rising prevalence of diabetes and the increasing adoption of insulin pumps for precise, continuous insulin delivery. Growing awareness of advanced diabetes management and supportive healthcare initiatives further accelerates demand.
By country, Brazil accounted for the largest share of the market in 2024.
The Latin America infusion pump market is divided by country, including Brazil, Mexico, Argentina, Colombia, Chile, Ecuador, Peru, and the Rest of Latin America. In 2024, Brazil accounted for the largest market share, driven by its large patient population and high prevalence of chronic diseases, fueling the demand for infusion therapies in oncology, diabetes, and critical care across leading hospital systems. The growing use of smart and ambulatory pumps, aided by advancements in hospital infrastructure and IT, accelerates adoption and replacement rates. Additionally, government and private healthcare investments and Brazil’s expansive supplementary health plans are enhancing procurement capacity and supporting standardization efforts that promote enterprise-wide infusion platforms and service agreements.
A breakdown of the primary participants (supply-side) for the Latin America infusion pumps market referred to in this report is provided below:
- By Company Type: Tier 1–45%, Tier 2–20%, and Tier 3–35%
- By Designation: C-level–35%, Director Level–25%, and Others–40%
- By Region: Brazil–40%, Mexico–25%, Argentina–20%, Colombia- 10%, and the Rest of Latin America- 5%.
The key players in the Latin America infusion pumps market include are Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Fresenius Kabi (Germany), Medtronic plc (Ireland), ICU Medical, Inc. (US), Terumo Corporation (Japan), Nipro Corporation (Japan), Avanos Medical, Inc. (US), JMS Co., Ltd. (Japan), Cardinal Health, Inc. (US), Roche Diagnostics (Switzerland), Abbott Laboratories (US), Danaher Corporation (US), Ypsomed Holding AG (Switzerland), and Tandem Diabetes Care, Inc. (US), Harvard Bioscience, Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), and Intuvie Holding LLC (US), among others.
Research Coverage:
The report analyzes the Latin America infusion pumps market and estimates the market size and future growth potential based on various segments such as devices & consumables, cancer type, procedure, end user, and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall Latin America infusion pumps market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
Analysis of key drivers (rising incidence of diabetes, growing geriatric population and subsequent rise in chronic diseases, rising number of surgical procedures, and the increasing adoption of enteral feeding pumps due to surge in pre-term births), restraints (stringent regulatory requirements for product commercialization, increasing adoption of refurbished & rented infusion pumps), opportunities (high growth potential in emerging economies and the increasing adoption of specialty infusion systems), challenges (increasing incidence of medication errors and inadequate wireless connectivity across several hospitals)
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the Latin America infusion pumps market. The report analyzes this market by product, application, and end user.
- Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the Latin America infusion pumps market
- Market Development: Comprehensive information on the lucrative emerging markets by product, application, and end user.
- Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the Latin America infusion pumps market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the Latin America infusion pumps market.
Table of Contents
1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.2.1 INCLUSIONS & EXCLUSIONS 26
1.2.2 MARKETS COVERED 27
1.2.3 YEARS CONSIDERED 28
1.2.4 CURRENCY CONSIDERED 28
1.3 MARKET STAKEHOLDERS 29
1.4 SUMMARY OF CHANGES 29
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH APPROACH 31
2.1.1 SECONDARY DATA 31
2.1.1.1 Key data from secondary sources 32
2.1.2 PRIMARY DATA 33
2.1.2.1 Primary sources 33
2.1.2.2 Key data from primary sources 34
2.1.2.3 Breakdown of primaries 34
2.2 MARKET SIZE ESTIMATION 35
2.3 GROWTH FORECAST 40
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 41
2.5 KEY INDUSTRY INSIGHTS 42
2.6 LIMITATIONS 42
2.6.1 METHODOLOGY-RELATED LIMITATIONS 42
2.7 RISK ASSESSMENT 43
2.8 STUDY ASSUMPTIONS 43
3 EXECUTIVE SUMMARY 44
4 PREMIUM INSIGHTS 53
4.1 LATAM INFUSION PUMPS MARKET OVERVIEW 53
4.2 LATAM INFUSION PUMPS MARKET, BY PRODUCT & COUNTRY, 2024 (USD MILLION) 54
4.3 LATAM INFUSION PUMPS MARKET: REGIONAL MIX 55
4.4 LATAM INFUSION PUMPS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 55
5 MARKET OVERVIEW 56
5.1 MARKET DYNAMICS 56
5.1.1 MARKET DRIVERS 57
5.1.1.1 Rising incidence of diabetes 57
5.1.1.2 Growing geriatric population and subsequent rise in chronic diseases 57
5.1.1.3 Rising number of surgical procedures 58
5.1.1.4 Increasing adoption of enteral feeding pumps due to surge in pre-term births 58
5.1.2 RESTRAINTS 59
5.1.2.1 Stringent regulatory requirements for product commercialization 59
5.1.2.2 Increasing adoption of refurbished & rented infusion pumps 59
5.1.3 OPPORTUNITIES 60
5.1.3.1 High growth potential in emerging economies 60
5.1.3.2 Increasing adoption of specialty infusion systems 60
5.1.4 CHALLENGES 60
5.1.4.1 Increasing incidence of medication errors and inadequate wireless connectivity across several hospitals 60
5.2 TECHNOLOGY ANALYSIS 61
5.2.1 KEY TECHNOLOGIES 61
5.2.1.1 Flow generation 61
5.2.1.2 Smart infusion systems 62
5.2.1.3 Closed-loop infusion control systems 62
5.2.2 COMPLEMENTARY TECHNOLOGIES 63
5.2.2.1 Dose-error reduction systems 63
5.2.2.2 Wireless connectivity 63
5.2.2.3 AI-powered decision support systems 64
5.2.3 ADJACENT TECHNOLOGIES 64
5.2.3.1 Embedded software 64
5.2.3.2 Sensing technology 64
5.3 PORTER’S FIVE FORCES ANALYSIS 65
5.3.1 THREAT OF NEW ENTRANTS 66
5.3.2 THREAT OF SUBSTITUTES 66
5.3.3 BARGAINING POWER OF SUPPLIERS 66
5.3.4 BARGAINING POWER OF BUYERS 67
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 67
5.4 REGULATORY ANALYSIS 67
5.4.1 REGULATORY LANDSCAPE 67
5.4.1.1 Brazil 67
5.4.1.2 Mexico 68
5.4.1.3 Argentina 68
5.4.1.4 Colombia 68
5.4.1.5 Chile 69
5.4.1.6 Ecuador 69
5.4.1.7 Peru 69
5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
5.5 PATENT ANALYSIS 71
5.5.1 PATENT PUBLICATION TRENDS FOR INFUSION PUMPS 71
5.5.2 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS 72
5.6 TRADE ANALYSIS 73
5.6.1 EXPORT DATA FOR HS CODE 901890 73
5.6.2 IMPORT DATA FOR HS CODE 901890 74
5.7 REIMBURSEMENT ANALYSIS 74
5.8 PRICING ANALYSIS 75
5.8.1 AVERAGE SELLING PRICE TREND FOR DEVICES, BY KEY PLAYER, 2022–2024 75
5.8.2 AVERAGE SELLING PRICE TREND OF INFUSION PUMPS, BY REGION, 2022–2024 76
5.9 KEY CONFERENCES & EVENTS, 2025–2026 76
5.10 KEY STAKEHOLDERS & BUYING CRITERIA 77
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 77
5.10.2 BUYING CRITERIA 77
5.11 IMPACT OF AI/GENERATIVE AI ON LATAM INFUSION PUMPS MARKET 78
5.11.1 INTRODUCTION 78
5.11.2 MARKET POTENTIAL IN LATAM INFUSION PUMPS ECOSYSTEM 78
5.11.3 KEY COMPANIES IMPLEMENTING AI IN INFUSION PUMPS 79
5.11.4 FUTURE OF GENERATIVE AI IN LATAM INFUSION PUMPS ECOSYSTEM 79
5.12 ECOSYSTEM ANALYSIS 80
5.13 VALUE CHAIN ANALYSIS 80
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82
5.15 INVESTMENT & FUNDING SCENARIO 82
5.16 TRUMP TARIFF IMPACT ON LATAM INFUSION PUMPS MARKET 83
5.16.1 INTRODUCTION 83
5.16.2 KEY TARIFF RATES 84
5.16.3 PRICE IMPACT ANALYSIS 84
5.16.4 IMPACT ON LATAM REGION 85
5.16.5 IMPACT ON END-USE INDUSTRIES 85
6 LATIN AMERICA INFUSION PUMPS MARKET, BY PRODUCT 87
6.1 INTRODUCTION 88
6.2 ACCESSORIES & CONSUMABLES 88
6.2.1 DEDICATED ACCESSORIES & CONSUMABLES 91
6.2.1.1 Volumetric infusion pump dedicated disposables 94
6.2.1.1.1 High adoption across hospitals & clinical settings to fuel uptake 94
6.2.1.2 Insulin infusion pump dedicated disposables 95
6.2.1.2.1 Rising number of insulin-dependent diabetic patients to support market growth 95
6.2.1.3 Enteral infusion pump dedicated disposables 96
6.2.1.3.1 Precision & consistency in results to fuel uptake 96
6.2.1.4 Syringe infusion pump dedicated disposables 97
6.2.1.4.1 High demand in developed countries to aid market 97
6.2.1.5 Ambulatory infusion pump dedicated disposables 99
6.2.1.5.1 Growth in home healthcare market to boost demand 99
6.2.1.6 PCA pump dedicated disposables 100
6.2.1.6.1 Increasing demand for critical pain management to boost market 100
6.2.1.7 Implantable infusion pump dedicated disposables 101
6.2.1.7.1 High compatibility with pumps to fuel uptake 101
6.2.2 NON-DEDICATED ACCESSORIES & CONSUMABLES 102
6.2.2.1 Infusion catheters 104
6.2.2.1.1 Potential for recurrent use to drive demand 104
6.2.2.2 IV administration sets 105
6.2.2.2.1 Rising demand for use in various systems to propel market 105
6.2.2.3 Needleless connectors 106
6.2.2.3.1 Reduction in bloodstream infection risks to boost demand 106
6.2.2.4 Cannulas 107
6.2.2.4.1 Ability to ease patient discomfort to boost demand 107
6.2.2.5 Tubing & extension sets 108
6.2.2.5.1 Need for continuous & efficient connections to fuel uptake 108
6.2.2.6 Valves 110
6.2.2.6.1 Improvement in quality of infusion to drive market 110
6.2.2.7 Other non-dedicated accessories & consumables 111
6.3 DEVICES 112
6.3.1 DEVICES MARKET, BY PRODUCT 113
6.3.1.1 Volumetric infusion pumps 114
6.3.1.1.1 Technological improvements to boost market 114
6.3.1.2 Insulin pumps 115
6.3.1.2.1 High demand from diabetics to propel market 115
6.3.1.3 Ambulatory infusion pumps 117
6.3.1.3.1 Rising cancer prevalence and increasing patient awareness to fuel market 117
6.3.1.4 Syringe infusion pumps 118
6.3.1.4.1 Cost-effectiveness and portability to boost demand 118
6.3.1.5 Enteral infusion pumps 120
6.3.1.5.1 Technological advancements to bolster market 120
6.3.1.6 PCA pumps 121
6.3.1.6.1 Growth in pain management to fuel uptake 121
6.3.1.7 Implantable infusion pumps 122
6.3.1.7.1 Growing use of long-term delivery of opioid medication to boost market 122
6.3.2 DEVICES MARKET, BY TECHNOLOGY 123
6.3.2.1 Traditional infusion pumps 124
6.3.2.1.1 Growing use in long-term care settings to drive demand 124
6.3.2.2 Specialty infusion pumps 125
6.3.2.2.1 Rising adoption in home care settings to drive market 125
6.3.3 DEVICES MARKET, BY TYPE 126
6.3.3.1 Stationary infusion pumps 127
6.3.3.1.1 High adoption in hospitals to drive market 127
6.3.3.2 Portable infusion pumps 128
6.3.3.2.1 Technological advancements to support market growth 128
7 LATIN AMERICA INFUSION PUMPS MARKET, BY APPLICATION 130
7.1 INTRODUCTION 131
7.2 CHEMOTHERAPY/ONCOLOGY 131
7.2.1 GROWING INCIDENCE OF CANCER TO DRIVE MARKET 131
7.3 DIABETES MANAGEMENT 133
7.3.1 RISING DEMAND FOR EFFECTIVE DIABETES TREATMENT TO BOOST MARKET 133
7.4 GASTROENTEROLOGY 135
7.4.1 GROWING UPTAKE IN GASTROINTESTINAL DISEASE TREATMENT TO FUEL MARKET 135
7.5 ANALGESIA/PAIN MANAGEMENT 137
7.5.1 RISING NUMBER OF SURGICAL PROCEDURES TO AID MARKET 137
7.6 PEDIATRICS/NEONATOLOGY 138
7.6.1 INCREASING INCIDENCE OF PEDIATRIC DIABETES TO SUPPORT MARKET GROWTH 138
7.7 HEMATOLOGY 139
7.7.1 INCREASING PREVALENCE OF BLOOD DISORDERS TO BOOST DEMAND 139
7.8 OTHER APPLICATIONS 141
8 LATIN AMERICA INFUSION PUMPS MARKET, BY END USER 143
8.1 INTRODUCTION 144
8.2 HOSPITALS 144
8.2.1 RISING INCIDENCE OF CHRONIC DISEASES AND GROWING FOCUS ON INFUSION THERAPY TO DRIVE MARKET 144
8.3 HOME CARE SETTINGS 146
8.3.1 RISING TECHNOLOGICAL ADVANCEMENTS IN PORTABLE & USER-FRIENDLY DEVICES TO PROPEL MARKET 146
8.4 AMBULATORY CARE SETTINGS 146
8.4.1 RISING NUMBER OF SURGICAL PROCEDURES TO BOOST MARKET 146
8.5 ACADEMIC & RESEARCH INSTITUTES 148
8.5.1 INCREASING MEDICAL RESEARCH ACTIVITIES TO SUPPORT MARKET GROWTH 148
8.6 ONCOLOGY CENTERS 149
8.6.1 GROWING FOCUS ON THERAPEUTICS TO FUEL UPTAKE 149
8.7 OTHER END USERS 150
9 LATIN AMERICA INFUSION PUMPS MARKET, BY COUNTRY 151
9.1 LATIN AMERICA 152
9.1.1 LATAM INFUSION PUMP DEVICES MARKET, BY PRODUCT, 2023–2030 (THOUSAND UNITS) 153
9.1.2 MACROECONOMIC OUTLOOK FOR LATAM COUNTRIES 154
9.1.3 BRAZIL 154
9.1.3.1 Increasing number of chronic conditions to drive market 154
9.1.4 MEXICO 159
9.1.4.1 Favorable government initiatives for commercialization of medical devices to boost market 159
9.1.5 ARGENTINA 164
9.1.5.1 Rapid aging population and subsequent rise in chronic diseases to boost market 164
9.1.6 COLOMBIA 169
9.1.6.1 Integration of technological advancements in hospitals & infusion therapy settings to propel market 169
9.1.7 CHILE 174
9.1.7.1 Growing focus on local infusion-therapy product manufacturers to fuel uptake 174
9.1.8 ECUADOR 178
9.1.8.1 Digital health initiatives to support market growth 178
9.1.9 PERU 183
9.1.9.1 Increasing focus on oncology therapeutics to boost market 183
9.1.10 REST OF LATIN AMERICA 187
10 COMPETITIVE LANDSCAPE 193
10.1 OVERVIEW 193
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025 193
10.3 REVENUE ANALYSIS, 2022–2024 195
10.4 MARKET SHARE ANALYSIS, 2024 195
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 197
10.5.1 STARS 198
10.5.2 EMERGING LEADERS 198
10.5.3 PERVASIVE PLAYERS 198
10.5.4 PARTICIPANTS 198
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 200
10.5.5.1 Company footprint 200
10.5.5.2 Country footprint 201
10.5.5.3 Product footprint 202
10.5.5.4 Application footprint 203
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 204
10.6.1 PROGRESSIVE COMPANIES 204
10.6.2 RESPONSIVE COMPANIES 204
10.6.3 DYNAMIC COMPANIES 204
10.6.4 STARTING BLOCKS 204
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 206
10.6.5.1 Detailed list of key startups/SMEs 206
10.6.6 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 207
10.6.6.1 Competitive benchmarking of key startups/SMEs 207
10.7 R&D EXPENDITURE OF KEY PLAYERS 208
10.8 COMPANY VALUATION AND FINANCIAL METRICS 208
10.8.1 COMPANY VALUATION 208
10.8.2 FINANCIAL METRICS 209
10.9 BRAND/PRODUCT COMPARATIVE ANALYSIS 209
10.10 COMPETITIVE SCENARIO 210
10.10.1 PRODUCT LAUNCHES & APPROVALS 210
10.10.2 DEALS 211
10.10.3 EXPANSIONS 212
10.10.4 OTHER DEVELOPMENTS 213
11 COMPANY PROFILES 214
11.1 KEY PLAYERS 214
11.1.1 BECTON, DICKINSON AND COMPANY (BD) 214
11.1.1.1 Business overview 214
11.1.1.2 Products offered 215
11.1.1.3 Recent developments 218
11.1.1.3.1 Product launches & approvals 218
11.1.1.3.2 Deals 219
11.1.1.3.3 Expansions 219
11.1.1.3.4 Other developments 220
11.1.1.4 MnM view 220
11.1.1.4.1 Key strengths 220
11.1.1.4.2 Strategic choices 220
11.1.1.4.3 Weaknesses & competitive threats 220
11.1.2 B. BRAUN MELSUNGEN AG 221
11.1.2.1 Business overview 221
11.1.2.2 Products offered 222
11.1.2.3 Recent developments 227
11.1.2.3.1 Product launches & approvals 227
11.1.2.3.2 Deals 228
11.1.2.3.3 Other developments 228
11.1.2.4 MnM view 229
11.1.2.4.1 Key strengths 229
11.1.2.4.2 Strategic choices 229
11.1.2.4.3 Weaknesses & competitive threats 229
11.1.3 BAXTER INTERNATIONAL INC. 230
11.1.3.1 Business overview 230
11.1.3.2 Products offered 231
11.1.3.3 Recent developments 233
11.1.3.3.1 Product approvals 233
11.1.3.3.2 Deals 233
11.1.3.3.3 Other developments 233
11.1.3.4 MnM view 234
11.1.3.4.1 Key strengths 234
11.1.3.4.2 Strategic choices 234
11.1.3.4.3 Weaknesses & competitive threats 234
11.1.4 FRESENIUS KABI 235
11.1.4.1 Business overview 235
11.1.4.2 Products offered 236
11.1.4.3 Recent developments 239
11.1.4.3.1 Product approvals 239
11.1.4.3.2 Deals 239
11.1.4.3.3 Other developments 240
11.1.4.4 MnM view 240
11.1.4.4.1 Key strengths 240
11.1.4.4.2 Strategic choices 240
11.1.4.4.3 Weaknesses & competitive threats 241
11.1.5 MEDTRONIC 242
11.1.5.1 Business overview 242
11.1.5.2 Products offered 243
11.1.5.3 Recent developments 244
11.1.5.3.1 Product launches & approvals 244
11.1.5.3.2 Deals 245
11.1.5.4 MnM view 245
11.1.5.4.1 Key strengths 245
11.1.5.4.2 Strategic choices 246
11.1.5.4.3 Weaknesses & competitive threats 246
11.1.6 TERUMO CORPORATION 247
11.1.6.1 Business overview 247
11.1.6.2 Products offered 248
11.1.6.3 Recent developments 249
11.1.6.3.1 Product launches 249
11.1.6.3.2 Deals 250
11.1.6.3.3 Expansions 250
11.1.7 ICU MEDICAL, INC. 251
11.1.7.1 Business overview 251
11.1.7.2 Products offered 252
11.1.7.3 Recent developments 254
11.1.7.3.1 Product approvals 254
11.1.7.3.2 Deals 254
11.1.7.3.3 Other developments 254
11.1.8 AVANOS MEDICAL, INC. 255
11.1.8.1 Business overview 255
11.1.8.2 Products offered 256
11.1.9 NIPRO CORPORATION 258
11.1.9.1 Business overview 258
11.1.9.2 Products offered 259
11.1.9.3 Recent developments 260
11.1.9.3.1 Expansions 260
11.1.10 JMS CO., LTD. 261
11.1.10.1 Business overview 261
11.1.10.2 Products offered 263
11.1.11 CARDINAL HEALTH, INC. 264
11.1.11.1 Business overview 264
11.1.11.2 Products offered 266
11.1.12 ROCHE DIAGNOSTICS 267
11.1.12.1 Business overview 267
11.1.12.2 Products offered 269
11.1.12.3 Recent developments 269
11.1.12.3.1 Expansions 269
11.1.13 ABBOTT LABORATORIES 270
11.1.13.1 Business overview 270
11.1.13.2 Products offered 271
11.1.14 DANAHER CORPORATION 272
11.1.14.1 Business overview 272
11.1.14.2 Products offered 274
11.1.15 YPSOMED AG 275
11.1.15.1 Business overview 275
11.1.15.2 Products offered 276
11.2 OTHER PLAYERS 277
11.2.1 TANDEM DIABETES CARE, INC. 277
11.2.2 HARVARD BIOSCIENCE INC. 278
11.2.3 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 279
11.2.4 INTUVIE HOLDINGS LLC 280
11.2.5 ANGIPLAST PVT. LTD. 281
11.2.6 IRADIMED CORPORATION 282
11.2.7 NEW ERA INSTRUMENTS 283
11.2.8 EPIC MEDICAL 284
11.2.9 SHENZHEN MEDRENA BIOTECH CO., LTD. 285
11.2.10 CODAN COMPANIES 285
12 APPENDIX 287
12.1 DISCUSSION GUIDE 287
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 293
12.3 CUSTOMIZATION OPTIONS 295
12.3.1 PRODUCT ANALYSIS 295
12.3.2 GEOGRAPHIC ANALYSIS 295
12.3.3 COMPANY INFORMATION 295
12.3.4 MARKET SHARE ANALYSIS 295
12.4 RELATED REPORTS 295
12.5 AUTHOR DETAILS 296
LIST OF TABLES
TABLE 1 LATAM INFUSION PUMPS MARKET: INCLUSIONS & EXCLUSIONS 26
TABLE 2 STANDARD CURRENCY CONVERSION RATES (USD) 28
TABLE 3 LATAM INFUSION PUMPS MARKET: RISK ASSESSMENT ANALYSIS 43
TABLE 4 LATAM INFUSION PUMPS MARKET: STUDY ASSUMPTIONS 43
TABLE 5 PORTER’S FIVE FORCES: IMPACT ANALYSIS 66
TABLE 6 LATIN AMERICA: LIST OF KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
TABLE 7 INFUSION PUMPS MARKET: MAJOR PATENTS 72
TABLE 8 EXPORT DATA FOR HS CODE 901890 (INCLUDING INFUSION PUMPS),
BY COUNTRY, 2021–2024 (USD THOUSAND) 73
TABLE 9 IMPORT DATA FOR HS CODE 901890 (INCLUDING INFUSION PUMPS),
BY COUNTRY, 2021–2024 (USD THOUSAND) 74
TABLE 10 AVERAGE SELLING PRICE TREND OF DEVICES, BY KEY PLAYER, 2022–2024 75
TABLE 11 AVERAGE SELLING PRICE TREND, LATAM REGION, 2022–2024 76
TABLE 12 LATAM INFUSION PUMPS MARKET: KEY CONFERENCES & EVENTS, 2025–2026 76
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR INFUSION PUMPS (%) 77
TABLE 14 KEY COMPANIES IMPLEMENTING AI IN INFUSION PUMPS 79
TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES 84
TABLE 16 KEY PRODUCT-RELATED TARIFF EFFECTIVE INFUSION PUMPS 84
TABLE 17 LATAM INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 88
TABLE 18 KEY PLAYERS PROVIDING INFUSION PUMP ACCESSORIES & CONSUMABLES 89
TABLE 19 ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 91
TABLE 20 ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 91
TABLE 21 KEY PLAYERS PROVIDING DEDICATED ACCESSORIES & CONSUMABLES 92
TABLE 22 DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 93
TABLE 23 DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 93
TABLE 24 KEY PLAYERS PROVIDING VOLUMETRIC INFUSION PUMP DEDICATED DISPOSABLES 94
TABLE 25 VOLUMETRIC INFUSION PUMP DEDICATED DISPOSABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 95
TABLE 26 KEY PLAYERS PROVIDING INSULIN INFUSION PUMP DEDICATED DISPOSABLES 96
TABLE 27 INSULIN INFUSION PUMP DEDICATED DISPOSABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 96
TABLE 28 KEY PLAYERS PROVIDING ENTERAL INFUSION PUMP DEDICATED DISPOSABLES 97
TABLE 29 ENTERAL INFUSION PUMP DEDICATED DISPOSABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 97
TABLE 30 KEY PLAYERS PROVIDING SYRINGE INFUSION PUMP DEDICATED DISPOSABLES 98
TABLE 31 SYRINGE INFUSION PUMP DEDICATED DISPOSABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 98
TABLE 32 KEY PLAYERS PROVIDING AMBULATORY INFUSION PUMP DEDICATED DISPOSABLES 99
TABLE 33 AMBULATORY INFUSION PUMP DEDICATED DISPOSABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99
TABLE 34 KEY PLAYERS PROVIDING PCA PUMP DEDICATED DISPOSABLES 100
TABLE 35 PCA PUMP DEDICATED DISPOSABLES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 100
TABLE 36 KEY PLAYERS PROVIDING IMPLANTABLE INFUSION PUMP DEDICATED DISPOSABLES 101
TABLE 37 IMPLANTABLE INFUSION PUMP DEDICATED DISPOSABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101
TABLE 38 KEY PLAYERS PROVIDING NON-DEDICATED ACCESSORIES & CONSUMABLES 102
TABLE 39 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 103
TABLE 40 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 103
TABLE 41 KEY PLAYERS PROVIDING INFUSION CATHETERS 104
TABLE 42 INFUSION CATHETERS NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 105
TABLE 43 KEY PLAYERS PROVIDING IV ADMINISTRATION SETS 106
TABLE 44 IV ADMINISTRATION SETS NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106
TABLE 45 KEY PLAYERS PROVIDING NEEDLELESS CONNECTORS 107
TABLE 46 NEEDLELESS CATHETERS NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107
TABLE 47 KEY PLAYERS PROVIDING CANNULAS 108
TABLE 48 CANNULAS NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 49 KEY PLAYERS PROVIDING TUBING & EXTENSION SETS 109
TABLE 50 TUBING & EXTENSION SETS NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 51 KEY PLAYERS PROVIDING VALVES 110
TABLE 52 VALVES NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110
TABLE 53 KEY PLAYERS PROVIDING OTHER NON-DEDICATED ACCESSORIES & CONSUMABLES 111
TABLE 54 OTHER NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 55 KEY PLAYERS PROVIDING INFUSION PUMP DEVICES 112
TABLE 56 LATAM INFUSION PUMPS DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 113
TABLE 57 LATAM INFUSION PUMPS DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 113
TABLE 58 KEY PLAYERS PROVIDING VOLUMETRIC INFUSION PUMPS 114
TABLE 59 VOLUMETRIC INFUSION PUMP DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 115
TABLE 60 KEY PLAYERS PROVIDING INSULIN PUMPS 116
TABLE 61 INSULIN PUMPS DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 62 KEY PLAYERS PROVIDING AMBULATORY INFUSION PUMPS 117
TABLE 63 AMBULATORY INFUSION PUMP DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 118
TABLE 64 KEY PLAYERS PROVIDING SYRINGE INFUSION PUMPS 119
TABLE 65 SYRINGE INFUSION PUMP DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 119
TABLE 66 KEY PLAYERS PROVIDING ENTERAL INFUSION PUMPS 120
TABLE 67 ENTERAL INFUSION PUMP DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 121
TABLE 68 KEY PLAYERS PROVIDING PCA PUMPS 121
TABLE 69 PCA PUMP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 70 KEY PLAYERS PROVIDING IMPLANTABLE INFUSION PUMPS 123
TABLE 71 IMPLANTABLE INFUSION PUMP DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 123
TABLE 72 INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 123
TABLE 73 KEY PLAYERS PROVIDING TRADITIONAL INFUSION PUMPS 124
TABLE 74 TRADITIONAL INFUSION PUMP TECHNOLOGY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 125
TABLE 75 KEY PLAYERS PROVIDING SPECIALTY INFUSION PUMPS 126
TABLE 76 SPECIALTY INFUSION PUMP TECHNOLOGY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 126
TABLE 77 INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 127
TABLE 78 KEY PLAYERS PROVIDING STATIONARY INFUSION PUMPS 127
TABLE 79 STATIONARY INFUSION PUMP DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 128
TABLE 80 KEY PLAYERS PROVIDING PORTABLE INFUSION PUMPS 128
TABLE 81 PORTABLE INFUSION PUMP DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 129
TABLE 82 LATAM INFUSION PUMP MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 131
TABLE 83 KEY PLAYERS PROVIDING INFUSION PUMPS FOR CHEMOTHERAPY/ONCOLOGY APPLICATIONS 132
TABLE 84 LATAM INFUSION PUMPS MARKET FOR CHEMOTHERAPY/ONCOLOGY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 85 KEY PLAYERS PROVIDING INFUSION PUMPS FOR DIABETES MANAGEMENT 134
TABLE 86 LATAM INFUSION PUMPS MARKET FOR DIABETES MANAGEMENT APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 134
TABLE 87 DISEASES & DISORDERS OF DIGESTIVE SYSTEM 135
TABLE 88 KEY PLAYERS PROVIDING INFUSION PUMPS FOR GASTROENTEROLOGY APPLICATIONS 136
TABLE 89 LATAM INFUSION PUMPS MARKET FOR GASTROENTEROLOGY APPLICATIONS,
BY COUNTRY, 2023–2030 (USD MILLION) 136
TABLE 90 KEY PLAYERS PROVIDING INFUSION PUMPS FOR ANALGESIA/PAIN MANAGEMENT APPLICATIONS 137
TABLE 91 LATAM INFUSION PUMPS MARKET FOR ANALGESIA/PAIN MANAGEMENT APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 92 KEY PLAYERS PROVIDING INFUSION PUMPS FOR PEDIATRICS/NEONATOLOGY APPLICATIONS 139
TABLE 93 LATAM INFUSION PUMPS MARKET FOR PEDIATRIC/NEONATOLOGY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 94 KEY PLAYERS PROVIDING LATAM INFUSION PUMPS FOR HEMATOLOGY APPLICATIONS 140
TABLE 95 LATAM INFUSION PUMPS MARKET FOR HEMATOLOGY APPLICATIONS,
BY COUNTRY, 2023–2030 (USD MILLION) 140
TABLE 96 KEY PLAYERS PROVIDING INFUSION PUMPS FOR OTHER APPLICATIONS 141
TABLE 97 LATAM INFUSION PUMPS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 98 LATAM INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 144
TABLE 99 LATAM INFUSION PUMPS MARKET FOR HOSPITALS, BY COUNTRY,
2023–2030 (USD MILLION) 145
TABLE 100 LATAM INFUSION PUMPS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 146
TABLE 101 LATAM INFUSION PUMPS MARKET FOR AMBULATORY CARE SETTINGS,
BY COUNTRY, 2023–2030 (USD MILLION) 147
TABLE 102 LATAM INFUSION PUMPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY COUNTRY, 2023–2030 (USD MILLION) 148
TABLE 103 INFUSION PUMPS MARKET FOR ONCOLOGY CENTERS, BY COUNTRY,
2023–2030 (USD MILLION) 149
TABLE 104 INFUSION PUMPS MARKET FOR OTHER END USERS, BY COUNTRY,
2023–2030 (USD MILLION) 150
TABLE 105 LATAM INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2023–2030 (THOUSAND UNITS) 153
TABLE 106 LATAM INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153
TABLE 107 BRAZIL: MACROECONOMIC INDICATORS 155
TABLE 108 BRAZIL: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 155
TABLE 109 BRAZIL: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 156
TABLE 110 BRAZIL: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 156
TABLE 111 BRAZIL: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 157
TABLE 112 BRAZIL: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 157
TABLE 113 BRAZIL: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 158
TABLE 114 BRAZIL: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 158
TABLE 115 BRAZIL: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 158
TABLE 116 BRAZIL: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 159
TABLE 117 MEXICO: MACROECONOMIC INDICATORS 160
TABLE 118 MEXICO: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 160
TABLE 119 MEXICO: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 161
TABLE 120 MEXICO: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 161
TABLE 121 MEXICO: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 162
TABLE 122 MEXICO: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 162
TABLE 123 MEXICO: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 163
TABLE 124 MEXICO: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 163
TABLE 125 MEXICO: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 163
TABLE 126 MEXICO: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 164
TABLE 127 ARGENTINA: MACROECONOMIC INDICATORS 165
TABLE 128 ARGENTINA: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 165
TABLE 129 ARGENTINA: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 165
TABLE 130 ARGENTINA: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 166
TABLE 131 ARGENTINA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 166
TABLE 132 ARGENTINA: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 167
TABLE 133 ARGENTINA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 167
TABLE 134 ARGENTINA: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 168
TABLE 135 ARGENTINA: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 168
TABLE 136 ARGENTINA: INFUSION PUMPS MARKET, BY END USER,
2023–2030 (USD MILLION) 169
TABLE 137 COLOMBIA: MACROECONOMIC INDICATORS 170
TABLE 138 COLOMBIA: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 170
TABLE 139 COLOMBIA: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 170
TABLE 140 COLOMBIA: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 171
TABLE 141 COLOMBIA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 171
TABLE 142 COLOMBIA: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 172
TABLE 143 COLOMBIA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 172
TABLE 144 COLOMBIA: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 173
TABLE 145 COLOMBIA: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 173
TABLE 146 COLOMBIA: INFUSION PUMPS MARKET, BY END USER,
2023–2030 (USD MILLION) 174
TABLE 147 CHILE: MACROECONOMIC INDICATORS 175
TABLE 148 CHILE: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 175
TABLE 149 CHILE: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 175
TABLE 150 CHILE: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 176
TABLE 151 CHILE: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 176
TABLE 152 CHILE: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 177
TABLE 153 CHILE: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 177
TABLE 154 CHILE: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 177
TABLE 155 CHILE: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 178
TABLE 156 CHILE: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 178
TABLE 157 ECUADOR: MACROECONOMIC INDICATORS 179
TABLE 158 ECUADOR: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 179
TABLE 159 ECUADOR: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 160 ECUADOR: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 180
TABLE 161 ECUADOR: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 181
TABLE 162 ECUADOR: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 181
TABLE 163 ECUADOR: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 182
TABLE 164 ECUADOR: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 182
TABLE 165 ECUADOR: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 182
TABLE 166 ECUADOR: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 183
TABLE 167 PERU: MACROECONOMIC INDICATORS 184
TABLE 168 PERU: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 184
TABLE 169 PERU: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 184
TABLE 170 PERU: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 185
TABLE 171 PERU: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 185
TABLE 172 PERU: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 186
TABLE 173 PERU: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 186
TABLE 174 PERU: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 175 PERU: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 187
TABLE 176 PERU: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 187
TABLE 177 REST OF LATINA AMERICA: INFUSION PUMPS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 188
TABLE 178 REST OF LATINA AMERICA: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 188
TABLE 179 REST OF LATINA AMERICA: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 189
TABLE 180 REST OF LATINA AMERICA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 189
TABLE 181 REST OF LATINA AMERICA: INFUSION PUMP DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 190
TABLE 182 REST OF LATINA AMERICA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 190
TABLE 183 REST OF LATINA AMERICA: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 191
TABLE 184 REST OF LATINA AMERICA: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 191
TABLE 185 REST OF LATINA AMERICA: INFUSION PUMPS MARKET, BY END USER,
2023–2030 (USD MILLION) 192
TABLE 186 LATAM INFUSION PUMPS MARKET: OVERVIEW OF STRATEGIES ADOPTED
BY KEY PLAYERS, 2022–2025 194
TABLE 187 LATAM INFUSION PUMPS MARKET: DEGREE OF COMPETITION 196
TABLE 188 LATAM INFUSION PUMPS MARKET: COUNTRY FOOTPRINT 201
TABLE 189 LATAM INFUSION PUMPS MARKET: PRODUCT FOOTPRINT 202
TABLE 190 LATAM INFUSION PUMPS MARKET: APPLICATION FOOTPRINT 203
TABLE 191 LATAM INFUSION PUMPS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 206
TABLE 192 LATAM INFUSION PUMPS MARKET: COMPETITIVE BENCHMARKING
OF KEY STARTUPS/SMES 207
TABLE 193 LATAM INFUSION PUMPS MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–AUGUST 2025 210
TABLE 194 LATAM INFUSION PUMPS MARKET: DEALS, JANUARY 2022–AUGUST 2025 211
TABLE 195 LATAM INFUSION PUMPS MARKET: EXPANSIONS, JANUARY 2022–AUGUST 2025 212
TABLE 196 LATAM INFUSION PUMPS MARKET: OTHER DEVELOPMENTS,
JANUARY 2022–MARCH 2025 213
TABLE 197 BD: COMPANY OVERVIEW 214
TABLE 198 BD: PRODUCTS OFFERED 215
TABLE 199 BD: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025 218
TABLE 200 BD: DEALS, JANUARY 2022–AUGUST 2025 219
TABLE 201 BD: EXPANSIONS, JANUARY 2022–AUGUST 2025 219
TABLE 202 BD: OTHER DEVELOPMENTS, JANUARY 2022–AUGUST 2025 220
TABLE 203 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 221
TABLE 204 B. BRAUN MELSUNGEN AG: PRODUCTS OFFERED 222
TABLE 205 B. BRAUN MELSUNGEN AG: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–AUGUST 2025 227
TABLE 206 B. BRAUN MELSUNGEN AG: DEALS, JANUARY 2022–AUGUST 2025 228
TABLE 207 B. BRAUN MELSUNGEN AG: OTHER DEVELOPMENTS,
JANUARY 2022–AUGUST 2025 228
TABLE 208 BAXTER INTERNATIONAL INC.: COMPANY OVERVIEW 230
TABLE 209 BAXTER INTERNATIONAL INC.: PRODUCTS OFFERED 231
TABLE 210 BAXTER INTERNATIONAL INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–AUGUST 2025 233
TABLE 211 BAXTER INTERNATIONAL INC.: DEALS, JANUARY 2022–AUGUST 2025 233
TABLE 212 BAXTER INTERNATIONAL INC.: OTHER DEVELOPMENTS,
JANUARY 2022–AUGUST 2025 233
TABLE 213 FRESENIUS KABI: COMPANY OVERVIEW 235
TABLE 214 FRESENIUS KABI: PRODUCTS OFFERED 236
TABLE 215 FRESENIUS KABI: PRODUCT APPROVALS, JANUARY 2022–AUGUST 2025 239
TABLE 216 FRESENIUS KABI: DEALS, JANUARY 2022–AUGUST 2025,
JANUARY 2022–AUGUST 2025 239
TABLE 217 FRESENIUS KABI: OTHER DEVELOPMENTS, JANUARY 2022–AUGUST 2025 240
TABLE 218 MEDTRONIC: COMPANY OVERVIEW 242
TABLE 219 MEDTRONIC PLC: PRODUCTS OFFERED 243
TABLE 220 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–AUGUST 2025 244
TABLE 221 MEDTRONIC: DEALS, JANUARY 2022–AUGUST 2025 245
TABLE 222 TERUMO CORPORATION: COMPANY OVERVIEW 247
TABLE 223 TERUMO CORPORATION: PRODUCTS OFFERED 248
TABLE 224 TERUMO CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025 249
TABLE 225 TERUMO CORPORATION: DEALS, JANUARY 2022–AUGUST 2025 250
TABLE 226 TERUMO CORPORATION: EXPANSIONS, JANUARY 2022–AUGUST 2025 250
TABLE 227 ICU MEDICAL, INC.: COMPANY OVERVIEW 251
TABLE 228 ICU MEDICAL, INC.: PRODUCTS OFFERED 252
TABLE 229 ICU MEDICAL, INC.: PRODUCT APPROVALS, JANUARY 2022–AUGUST 2025 254
TABLE 230 ICU MEDICAL, INC.: DEALS, JANUARY 2022–AUGUST 2025 254
TABLE 231 ICU MEDICAL, INC.: OTHER DEVELOPMENTS 254
TABLE 232 AVANOS MEDICAL, INC.: COMPANY OVERVIEW 255
TABLE 233 AVANOS MEDICAL, INC.: PRODUCTS OFFERED 256
TABLE 234 NIPRO CORPORATION: COMPANY OVERVIEW 258
TABLE 235 NIPRO CORPORATION: PRODUCTS OFFERED 259
TABLE 236 NIPRO CORPORATION: EXPANSIONS, JANUARY 2022–AUGUST 2025 260
TABLE 237 JMS CO., LTD.: COMPANY OVERVIEW 261
TABLE 238 JMS CO., LTD.: PRODUCTS OFFERED 263
TABLE 239 CARDINAL HEALTH, INC.: COMPANY OVERVIEW 264
TABLE 240 CARDINAL HEALTH, INC.: PRODUCTS OFFERED 266
TABLE 241 ROCHE DIAGNOSTICS: COMPANY OVERVIEW 267
TABLE 242 ROCHE DIAGNOSTICS: PRODUCTS OFFERED 269
TABLE 243 ROCHE DIAGNOSTICS: EXPANSIONS, JANUARY 2022–AUGUST 2025 269
TABLE 244 ABBOTT LABORATORIES: COMPANY OVERVIEW 270
TABLE 245 ABBOTT LABORATORIES: PRODUCTS OFFERED 271
TABLE 246 DANAHER CORPORATION: COMPANY OVERVIEW 272
TABLE 247 DANAHER CORPORATION: PRODUCTS OFFERED 274
TABLE 248 YPSOMED AG: COMPANY OVERVIEW 275
TABLE 249 YPSOMED AG: PRODUCTS OFFERED 276
TABLE 250 TANDEM DIABETES CARE, INC.: COMPANY OVERVIEW 277
TABLE 251 HARVARD BIOSCIENCE INC.: COMPANY OVERVIEW 278
TABLE 252 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 279
TABLE 253 INTUVIE HOLDINGS LLC: COMPANY OVERVIEW 280
TABLE 254 ANGIPLAST PVT. LTD.: COMPANY OVERVIEW 281
TABLE 255 IRADIMED CORPORATION: COMPANY OVERVIEW 282
TABLE 256 NEW ERA INSTRUMENTS: COMPANY OVERVIEW 283
TABLE 257 EPIC MEDICAL: COMPANY OVERVIEW 284
TABLE 258 SHENZHEN MEDRENA BIOTECH CO., LTD.: COMPANY OVERVIEW 285
TABLE 259 CODAN COMPANIES: COMPANY OVERVIEW 285
LIST OF FIGURES
FIGURE 1 LATAM INFUSION PUMPS MARKET & COUNTRY SEGMENTATION 27
FIGURE 2 RESEARCH DESIGN 31
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 34
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 35
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2024) 36
FIGURE 6 LATAM INFUSION PUMPS MARKET: SUPPLY-SIDE ANALYSIS 37
FIGURE 7 TOP-DOWN APPROACH 38
FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF LATAM INFUSION PUMPS MARKET, 2025–2030 39
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF LATAM INFUSION PUMPS MARKET (2025–2030) 40
FIGURE 10 DATA TRIANGULATION METHODOLOGY 41
FIGURE 11 KEY INDUSTRY INSIGHTS 42
FIGURE 12 LATAM INFUSION PUMPS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 44
FIGURE 13 LATAM INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE,
2025 VS. 2030 (USD MILLION) 45
FIGURE 14 LATAM INFUSION PUMP DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2025 VS. 2030 (USD MILLION) 46
FIGURE 15 LATAM INFUSION PUMP NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 47
FIGURE 16 LATAM INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2025 VS. 2030 (USD MILLION) 48
FIGURE 17 LATAM INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2025 VS. 2030 (USD MILLION) 48
FIGURE 18 LATAM INFUSION PUMP DEVICES MARKET, BY TYPE,
2025 VS. 2030 (USD MILLION) 49
FIGURE 19 LATAM INFUSION PUMPS MARKET, BY APPLICATION,
2025 VS. 2030 (USD MILLION) 50
FIGURE 20 LATAM INFUSION PUMPS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 51
FIGURE 21 GEOGRAPHIC SNAPSHOT: LATAM INFUSION PUMPS MARKET 52
FIGURE 22 INCREASING INCIDENCE OF CHRONIC DISEASES TO PROPEL MARKET 53
FIGURE 23 ACCESSORIES & CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN BRAZIL IN 2024 54
FIGURE 24 DEVELOPED COUNTRIES TO GROW AT HIGHER GROWTH RATES DURING FORECAST PERIOD 55
FIGURE 25 COLOMBIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 55
FIGURE 26 LATAM INFUSION PUMPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
FIGURE 27 PEOPLE WITH DIABETES (20–79 YEARS), BY COUNTRY,
2021 VS. 2045 (IN THOUSANDS) 57
FIGURE 28 LATAM INFUSION PUMPS MARKET: PORTER’S FIVE FORCES ANALYSIS 65
FIGURE 29 LATAM INFUSION PUMPS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–AUGUST 2025) 71
FIGURE 30 TOP APPLICANT COUNTRIES/REGIONS FOR INFUSION PUMPS PATENTS
(JANUARY 2014–AUGUST 2025) 72
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR INFUSION PUMPS 77
FIGURE 32 KEY BUYING CRITERIA FOR INFUSION PUMPS, BY TOP 3 END USERS 78
FIGURE 33 LATAM INFUSION PUMPS MARKET: ECOSYSTEM ANALYSIS 80
FIGURE 34 LATAM INFUSION PUMPS MARKET: VALUE CHAIN ANALYSIS 81
FIGURE 35 REVENUE SHIFTS & NEW REVENUE POCKETS FOR LATAM INFUSION PUMPS MARKET 82
FIGURE 36 LATAM INFUSION PUMPS MARKET SNAPSHOT 152
FIGURE 37 LATAM INFUSION PUMPS MARKET: REVENUE ANALYSIS OF TOP FIVE PLAYERS, 2022–2024 195
FIGURE 38 MARKET SHARE ANALYSIS, 2024 196
FIGURE 39 LATAM INFUSION PUMPS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS, 2024 199
FIGURE 40 LATAM INFUSION PUMPS MARKET: COMPANY FOOTPRINT 200
FIGURE 41 LATAM INFUSION PUMPS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 205
FIGURE 42 R&D EXPENDITURE OF KEY PLAYERS IN LATAM INFUSION PUMPS
MARKET, 2022–2024 208
FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 208
FIGURE 44 EV/EBITDA OF KEY VENDORS 209
FIGURE 45 LATAM INFUSION PUMPS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 209
FIGURE 46 BD: COMPANY SNAPSHOT (2024) 215
FIGURE 47 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2024) 222
FIGURE 48 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2024) 231
FIGURE 49 FRESENIUS KABI: COMPANY SNAPSHOT (2024) 236
FIGURE 50 MEDTRONIC: COMPANY SNAPSHOT (2024) 243
FIGURE 51 TERUMO CORPORATION: COMPANY SNAPSHOT (2024) 248
FIGURE 52 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024) 252
FIGURE 53 AVANOS MEDICAL, INC.: COMPANY SNAPSHOT (2024) 256
FIGURE 54 NIPRO CORPORATION: COMPANY SNAPSHOT (2024) 259
FIGURE 55 JMS CO., LTD.: COMPANY SNAPSHOT (2024) 262
FIGURE 56 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2024) 265
FIGURE 57 ROCHE DIAGNOSTICS.: COMPANY SNAPSHOT (2024) 268
FIGURE 58 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2024) 271
FIGURE 59 DANAHER CORPORATION: COMPANY SNAPSHOT (2024) 273
FIGURE 60 YPSOMED AG: COMPANY SNAPSHOT (2024) 276
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11